Could this mum help transform treatment for MS?
A thirty-seven-year-old mum with multiple sclerosis has become the first patient in the UK to receive an experimental treatment that could slow or even stop progression of the disease. Emily Henders has had MS for four years, but existing drug treatments haven't worked, and three times she has woken to find she was unable to move her legs. She was given an infusion of her own cells that had been weaponised in the lab to hunt down rogue elements in her immune system that drive the disease’s disabling relapses. Sky News was given special permission to be present as the cells arrived deep-frozen in liquid nitrogen before being carefully thawed and infused into her bloodstream. Sky's science and medical correspondent Thomas Moore reports. #skynews #uk #multiplesclerosisawareness #ms #multiplesclerosis #experimental #drugtreatment SUBSCRIBE to our YouTube channel for more videos: / skynews Follow us on Twitter: / skynews Like us on Facebook: / skynews Follow us on Instagram: / skynews Follow us on TikTok: / skynews For more content go to http://news.sky.com and download our apps: Apple https://itunes.apple.com/gb/app/sky-n... Android https://play.google.com/store/apps/de... Sky News Daily podcast is available for free here: https://podfollow.com/skynewsdaily/ Sky News videos are now available in Spanish here/Los video de Sky News están disponibles en español aquí: / @skynewsespanol To enquire about licensing Sky News content, you can find more information here: https://news.sky.com/info/library-sales

Nebraska woman first to receive new MS treatment

We're Probably Going to Cure MS

The Psychological Impact of MS

Remyelination for MS: Remyelination Clincal Trials & more! - MS Exercise

How Proctor’s texts in Karen Read lawsuit could free dangerous criminals

"Are we any closer to finding a cure for vitiligo?"

MS patients given new hope in world first drug trial

A breath-based breakthrough in MS research | Valerie Verge | TEDxUniversityofSaskatchewan

7 Things you NEED To Know About Multiple Sclerosis (MS) in 2026

Revolutionary MS Treatment: CAR-T Cells Target Brain & Spinal Cord (2025 Update)

Reversing MS Symptoms? The Power of Remyelination

Emerging Therapies: Multiple Sclerosis Research Update December 2025

Risk of B-Cell Depleters Long-Term (Ocrevus, Rituximab, Kesimpta, Briumvi)

FIRST SIGNS / SYMPTOMS OF MS ⎥MY MULTIPLE SCLEROSIS STORY ⎥HOW I'M DOING RIGHT NOW ⎥Lii Borossy

Unheilbar krank: So lebt Janine mit Multiple Sklerose I 37°

The NEW 2024 MS Diagnostic Criteria Explained (Game-Changer!)

UCSF doctor wins award for groundbreaking MS treatment

Ocrevus vs. Kesimpta for Multiple Sclerosis. Comparison Between the Drugs, Efficacy, Side Effects

Paralyzed, Blind & Hospitalized-Aggressive MS at 23/My MS Story

